Skip to main content
Clinical Trials/NCT03263884
NCT03263884
Completed
Not Applicable

Repetitive Transcranial Magnetic Stimulation and the Development of Ongoing Muscle Pain

Aalborg University1 site in 1 country30 target enrollmentAugust 1, 2017
ConditionsPain Relief

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain Relief
Sponsor
Aalborg University
Enrollment
30
Locations
1
Primary Endpoint
Pain relief
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The main purpose of the study is to assess the mechanisms of repeated sessions of repetitive trancranial magnetic stimulation (rTMS) applied on left dorsolateral prefrontal cortex on the development of pain in a prolonged muscle pain model.

Detailed Description

This study aims to investigate whether i) rTMS of left DLPFC will reduce the severity and duration of experimentally induced muscle pain when a 5-day course of treatment is given immediately following an initial nerve growth factor (NGF) injection; ii) the analgesic effects of left DLPFC rTMS will be related to an improved cognitive network function as assessed by electroencephalography (EEG).

Registry
clinicaltrials.gov
Start Date
August 1, 2017
End Date
February 28, 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Aalborg University
Responsible Party
Principal Investigator
Principal Investigator

Enrico De Martino

Medical Doctor

Aalborg University

Eligibility Criteria

Inclusion Criteria

  • Healthy men and women
  • Speak and understand English.

Exclusion Criteria

  • Pregnancy
  • Drug addiction defined as the use of cannabis, opioids or other drugs
  • Previous neurologic, musculoskeletal or mental illnesses
  • Lack of ability to cooperate
  • History of chronic pain or current acute pain
  • Previous experience with rTMS
  • Contraindications to rTMS application (history of epilepsy, metal in the head or jaw etc.).
  • Failure to pass the "TASS questionnaire" (TASS = Transcranial Magnetic Stimulation Adult Safety Screen)

Outcomes

Primary Outcomes

Pain relief

Time Frame: Change from baseline at 2 weeks

Pain on an 11-point numerical rating scale (0 = no pain, 10 = most intense pain imaginable)

Secondary Outcomes

  • Muscle soreness(Change from baseline at 2 weeks)
  • Patient-rated Tennis Elbow Evaluation(Change from baseline at 2 weeks)
  • Attention network test(Change from baseline at 2 weeks)
  • Pressure pain thresholds(Change from baseline at 2 weeks)
  • Cuff pressure algometry(Change from baseline at 2 weeks)
  • EEG recordings(Change from baseline at 1 weeks)

Study Sites (1)

Loading locations...

Similar Trials